Reaction

Bone Marrow Transplant Rejection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 220 reports · 9 co-occurring drugs

As of the last recalculation, Bone Marrow Transplant Rejection appears in 220 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 257.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fludarabine Phosphate72257.0257.5
Busulfan31216.8217.2
Valproate Sodium25129.0129.1
Alemtuzumab1895.895.9
Phenytoin1783.483.5
Thiotepa882.282.3
Melphalan Hydrochloride1560.760.7
Anti-Thymocyte Globulin (Rabbit)560.060.0
Melphalan1357.457.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.